600111:SSEChina Northern Rare Earth (Group) High-Tech Co., Ltd. Class A Analysis
Data as of 2026-06-11 - not real-time
CN¥47.52
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
China Northern Rare Earth is trading below its 20‑day and 200‑day moving averages, with a neutral trend and a bearish MACD histogram, suggesting limited upside in the near term. Volume is decreasing and volatility remains elevated, while the price sits near a defined support level, indicating potential downside risk if sentiment turns negative.
Fundamentally, the company shows strong revenue growth but thin margins, a very high price‑to‑earnings multiple, and a price‑to‑book ratio well above peers. Debt levels are high relative to equity and free cash flow is negative, raising concerns about cash generation despite a modest dividend payout. The sector faces medium to high regulatory scrutiny in China, and the rare‑earth market is subject to policy‑driven supply dynamics.
Fundamentally, the company shows strong revenue growth but thin margins, a very high price‑to‑earnings multiple, and a price‑to‑book ratio well above peers. Debt levels are high relative to equity and free cash flow is negative, raising concerns about cash generation despite a modest dividend payout. The sector faces medium to high regulatory scrutiny in China, and the rare‑earth market is subject to policy‑driven supply dynamics.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Bearish MACD and price below short‑term averages
- Proximity to technical support
- Decreasing volume and high short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth but thin profitability
- Elevated valuation multiples relative to earnings
- High debt load and negative free cash flow
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Strategic importance of rare‑earth materials for clean‑energy technologies
- Potential for improved cash generation as market demand expands
- Long‑term secular tailwinds outweigh current valuation concerns
Key Metrics & Analysis
Financial Health
Revenue Growth27.70%
Profit Margin6.07%
P/E Ratio62.5
ROE10.96%
ROA5.19%
Debt/Equity29.95
P/B Ratio6.7
Op. Cash FlowCN¥433.0M
Free Cash FlowCN¥-1013850112
Technical Analysis
TrendNeutral
RSI43.1
SupportCN¥46.26
ResistanceCN¥55.88
MA 20CN¥49.76
MA 50CN¥50.40
MA 200CN¥49.68
MACDBearish
VolumeDecreasing
Fear & Greed Index86.71
Valuation
Fair ValueCN¥1.81
GradeOvervalued
TypeGrowth
Dividend Yield0.27%
Risk Assessment
Beta0.50
Volatility59.35%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.